Foghorn Therapeutics Inc.
NASDAQ:FHTX

Watchlist Manager
Foghorn Therapeutics Inc. Logo
Foghorn Therapeutics Inc.
NASDAQ:FHTX
Watchlist
Price: 8.85 USD -0.11% Market Closed
Market Cap: 489.7m USD
Have any thoughts about
Foghorn Therapeutics Inc.?
Write Note

Wall Street
Price Targets

FHTX Price Targets Summary
Foghorn Therapeutics Inc.

Wall Street analysts forecast FHTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FHTX is 16.32 USD with a low forecast of 9.09 USD and a high forecast of 21 USD.

Lowest
Price Target
9.09 USD
3% Upside
Average
Price Target
16.32 USD
84% Upside
Highest
Price Target
21 USD
137% Upside

FHTX Last Price Targets
Foghorn Therapeutics Inc.

The latest public price target was made on Sep 24, 2024 by Vikram Purohit from Morgan Stanley , who expects FHTX stock to rise by 2% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Vikram Purohit
Morgan Stanley
9 USD
Upside 2%
1 month ago
Sep 24, 2024
Foghorn Therapeutics (FHTX) PT Raised to $9 at Morgan Stanley
StreetInsider
Gavin Clark-Gartner
Evercore ISI
20 USD
Upside 126%
2 months ago
Aug 19, 2024
Foghorn Therapeutics initiated with an Outperform at Evercore ISI
TheFly
Vikram Purohit
Morgan Stanley
Price Target 9 USD
Upside/Downside 2%
View Source
Gavin Clark-Gartner
Evercore ISI
Price Target 20 USD
Upside/Downside 126%
View Source
Foghorn Therapeutics Inc. Competitors:
Price Targets
ALGEN
Genoway SA
93% Upside
603087
Gan & Lee Pharmaceuticals
39% Upside
MDGL
Madrigal Pharmaceuticals Inc
17% Upside
ASND
Ascendis Pharma A/S
61% Upside
AMGN
Amgen Inc
13% Upside
RPTX
Repare Therapeutics Inc
329% Upside
OSTX
OS Therapies Inc
482% Upside
MAB
Mabion SA
37% Upside

Revenue
Forecast

Revenue Estimate
Foghorn Therapeutics Inc.

The compound annual growth rate of Foghorn Therapeutics Inc.'s revenue for the next 3 years is 7%.

N/A
Past Growth
7%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Foghorn Therapeutics Inc.

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Foghorn Therapeutics Inc.

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is FHTX's stock price target?
Price Target
16.32 USD

According to Wall Street analysts, the average 1-year price target for FHTX is 16.32 USD with a low forecast of 9.09 USD and a high forecast of 21 USD.

What is Foghorn Therapeutics Inc.'s Revenue forecast?
Projected CAGR
7%

The compound annual growth rate of Foghorn Therapeutics Inc.'s revenue for the next 3 years is 7%.

Back to Top